All of the following were taken from
www.theheart.org . Please go there for additional info:
No increased death, MI with DES in randomized trials and registries, "mega"-meta-analysis suggests
Mar 29, 2008 09:00 EDT / The study, presented at an ACC satellite session, combined all known randomized trials and registry studies of Cypher and Taxus drug-eluting stents vs bare-metal stents and suggests that DES are just as safe as bare-metal stents, even when used off label and in the "real world." (American College of Cardiology 2008 Scientific Sessions.)
Mortality reduced at two years in AMI patients treated with DES: Massachusetts registry
Apr 3, 2008 14:45 EDT / Investigators suggest that lower revascularization rates in DES-treated vs bare-metal-stent-treated patients may have driven the improved survival, but they also emphasize that the real message is the lack of signal of harm. (American College of Cardiology 2008 Scientific Sessions.)
Stents equivalent to surgery in left main disease
Mar 31, 2008 14:45 EDT / New registry data from Korea indicate that stenting the left main coronary artery is as safe as performing bypass surgery. The results were hailed as impressive, but most observers say it will be necessary to wait for the results of SYNTAXan ongoing randomized trial in the USbefore changing practice. (Seung KB et al. New Engl J Med; published online before print March 31, 2008. American College of Cardiology 2008 Scientific Sessions.)
Off-site PCI comparable to PCI with on-site backup
Apr 2, 2008 16:00 EDT / UPDATED WITH VIDEO INTERVIEW // The largest-ever clinical analysis and comparison of PCI centers with and without surgical backup in the US has shown that PCI facilities without on-site surgery have similar outcomes to centers with traditional backup. (American College of Cardiology 2008 Scientific Sessions.)
Percutaneous valve clip reduces mitral regurgitation and reverse remodeling in functional MR patients
Apr 1, 2008 16:00 EDT / Over 12 months, the percutaneous procedure that emulates edge-to-edge mitral-valve repair appears to reduce mitral regurgitation and improve LV dimentions/function in patients with functional MR successfully treated with the device. (American College of Cardiology 2008 Scientific Sessions)